logo
History Shows the Danger of Trump's Health Policies

History Shows the Danger of Trump's Health Policies

Yahooa day ago

U.S. President Donald Trump and Health and Human Services Secretary Robert F. Kennedy Jr. attend an event in the East Room of the White House on May 22, 2025 in Washington, DC. Credit - Chip Somodevilla—Getty Images
On May 11, 2023, President Joseph Biden ended the COVID-19 public health emergency, calling an finish to the pandemic. By the end of 2023, COVID-19 claimed the lives of over 20 million people around the world. But through international cooperation and evidence-based science, vaccines were developed and the world moved on.
Indeed, perhaps the biggest success of the period was the quick production of a COVID-19 vaccine. The research behind the mRNA vaccine had been ongoing since the 1970s, but the emergency of the pandemic and international sharing of knowledge helped bring the vaccine to fruition. Today, the COVID-19 vaccine has been credited with saving 2.4 million lives around the world.
But now, the U.S. is choosing competition over cooperation. With President Donald Trump's day one executive order to leave the World Health Organization (WHO)—blaming their COVID-19 response—and the shuttering of USAID, the country is taking steps towards further dividing health efforts across the globe. Here in the U.S., a sudden end to $11.4 billion of covid-related grants is stifling national pandemic preparedness efforts on the local and state levels. And most recently, Health and Human Services Secretary RFK Jr. purged experts from the CDC Advisory Committee, putting lives at risk.
Historical lessons demonstrate the need for global health infrastructure that works together, shares knowledge, and remembers that pathogens do not stop at borders.
White House's Pandemic Office, Busy With Bird Flu, May Shrink Under Trump
One of the greatest global health achievements of all time—smallpox eradication—provides a perfect example of what can be done with independent scientific research and international cooperation. During the Cold War between the U.S. and USSR, decades of tension brought the world to the brink of nuclear war. Yet, incredibly, the nations managed to find common ground to support the efforts of smallpox eradication. Indeed, they understood the strategic benefits that came from letting public health practitioners and scientists work outside of political divides.
The WHO was founded after World War II in 1948. Its formation marked a move from international health, that focused on nations, to global health, that would serve humanity first. The WHO's first eradication effort was the failed, U.S.-backed, Malaria Eradication Program from 1955 to 1969. The Smallpox Eradication Program, with intensive efforts beginning in 1967, provided a chance for redemption for the U.S. and WHO.
For the United States, investing in disease eradication and poverty helped to mitigate growing backlash against the Vietnam War. In June of 1964, President Lyndon B. Johnson stated, 'I propose to dedicate this year to finding new techniques for making man's knowledge serve man's welfare.' He called for 1965—the same year he ordered ground troops to Vietnam to stop the spread of communism —to be a year of international cooperation that could bypass the politics of the Cold War.
Previously, the USSR did not participate in the U.S. and WHO's first, failed global eradication plan for malaria. But upon rejoining the WHO in 1956, it was the Soviets who made the first call and investment into global eradication of smallpox in 1958.
The WHO functioning as a mediator was crucial to allowing the USSR and the U.S. to work together. It allowed both nations to avoid giving credit to each other; rather success went to science itself. President Johnson called this 'a turning point' away from 'man against man' towards 'man against nature.'
The limited role of politicians in the program proved to be key to its success. Scientists made decisions and worked together—no matter what country they came from—by focusing on disease and vaccination, not international tensions. The Soviet-initiated program was lead by Donald A. Henderson, a U.S. epidemiologist, who worked alongside the Russians until the last case of smallpox occurred in Somalia on October 26, 1977.
During the 20th century, smallpox was responsible for an estimated 300 to 500 million deaths. Smallpox was officially declared eradicated by the WHO in October 1980, and is today still the only human disease to achieve this distinction.
Less than a year after the declaration of smallpox eradication, the emergence of another pandemic, the HIV/AIDS crisis, reinforced the importance of science-first cooperation over politically-driven decision making. In June 1981, the first cases of a new unknown disease were reported in the CDC's Morbidity and Mortality Weekly Report. In short order, gay men were stigmatized and blamed in what would become one of the biggest public health disasters of all time. It took years of grassroots science-based activism to move beyond HIV/AIDS victim-blaming and find medical solutions.
The Poster Child for AIDS Obscured as Much About the Crisis as He Revealed
Too often, governments across the globe placed blame on the gay community for their 'sins' and did not provide needed support, leaving the sick to suffer and die. The pharmaceutical companies profited from the limited medications they had available and did not pursue sufficient development. The FDA process for new drugs was scheduled to take nine years, at a time when life expectancy after receiving an HIV/AIDS diagnosis was one year. These issues sparked activism, spawning the AIDS Coalition to Unleash Power (ACT UP) in 1987.
ACT UP organizers took science into their own hands and began educating themselves. Members began reading scientific journals religiously, learning the chemistry and epidemiology of drug manufacturing and clinical trials. Members learned how to translate these dense scientific messages to educate the community members on what was—and what was not—being done to help. Because of this work, the FDA changed policies to allow for new treatments to be tested at accelerated rates in times of emergency. ACT UP was able to shift the cultural blame showing that the issue was a result of politics getting in the way of scientific advancements. By 1990, ACT UP influenced the largest federal HIV program to pass Congress, the Ryan White CARE Act. This program was a vital precursor to the 2003 PEPFAR (The U.S. President's Emergency Plan for AIDS Relief) global initiative.
Both of these histories offer a powerful lesson: global health is national health, and national health is local health. With the recent funding cuts from the U.S. government, the future of global health is going in an unknown direction. And yet, the occurrence of pandemics is expected to increase in frequency due to climate change, mass migration, urbanization, and ecosystem destruction. It has been estimated that there is about a 25% chance we will have another COVID-sized pandemic within the next 10 years. No matter how secure the world makes borders, history shows that it can not protect us from disease if we do not have a strong, interconnected public health infrastructure.
Luke Jorgensen is a Master of Public Health student at Purdue University where his epidemiology research examines human migration and infectious disease.
Made by History takes readers beyond the headlines with articles written and edited by professional historians. Learn more about Made by History at TIME here. Opinions expressed do not necessarily reflect the views of TIME editors.
Write to Made by History at madebyhistory@time.com.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Democrats slam military parade as Trump's multimillion-dollar 'birthday party'

time4 minutes ago

Democrats slam military parade as Trump's multimillion-dollar 'birthday party'

Congressional Democrats and at least one high-profile Republican are slamming the multimillion-dollar cost of the Army 's 250th anniversary parade on Saturday that President Donald Trump has long sought to celebrate the military. Trump has said the cost -- projected to be as much as $45 million for the Army alone, not counting security and other expenses -- will be "peanuts compared to the value of doing it." However, his critics argue the money could be better spent elsewhere. "If it was really about celebrating military families, we could put $30 million toward helping them offset the cost of their child care, food assistance and tuition," Sen. Tammy Duckworth said on X. "But it isn't. Trump is throwing himself a $30 million birthday parade just to stroke his own ego." The Army said it has accounted for spending between $25 million and $45 million on the parade, which will include 6,700 troops and dozens of tanks, military fighting vehicles and aircraft staged on or near the National Mall. "Money should be put in medical defense research instead of wasted on some pomp and circumstance for the president," Sen. Dick Durbin, D-Ill., said during a Senate Appropriations Committee hearing with Defense Secretary Pete Hegseth on Wednesday. "This is not consistent with what the men and women in uniform deserve." Saturday's parade also falls on Trump's 79th birthday, and when it ends near the White House, the Army's Golden Knights parachute team will present him with an American flag, after which he'll administer the constitutional oath to Army enlistees. "We all like to enjoy a nice birthday party," Sen. Bernie Sanders, I-Vt., posted on X. "But most of us don't celebrate with a $45 million taxpayer-funded military parade. "Save taxpayer money. Have a birthday cake and blow out a few candles," he said. "Don't shut down the capital and roll out 60-ton tanks through the streets." "I wouldn't have done it," Kentucky Republican Sen. Rand Paul said. "We were always different than, you know, the images you saw in the Soviet Union and North Korea. We were proud not to be that." Some Democrats echoed that criticism. "It's outrageous," Rep. Yassamin Ansari, D-Ariz., said. "This is something that would happen in North Korea, not the United States of America. Donald Trump thinks he's a king. He's not. He was elected as president of the United States, and he should act as such." Army spokesman Steve Warren defended the parade, saying, "It is a lot of money, but I think that amount of money is dwarfed by 250 years of service and sacrifice that American soldiers have given this country. "We're looking at this as an opportunity to really strengthen the connection between America and her Army," he added. "So, yeah, it's a lot of money, but it pales in comparison to what we're selling." The White House this week also requested a flyover by the Air Force Thunderbirds. When asked Thursday what he hopes the public will remember about the parade, Trump said, "How great our country is, very simple, and how strong our military is." "We have the strongest military in the world," he added. The White House has not responded to requests for a total cost estimate that would include money spent on security and other arrangements. Several Republicans say they're skipping the parade due to prior commitments, including House Speaker Mike Johnson. Georgia Rep. Marjorie Taylor Greene said she would attend and defended the display. "Washington D.C. is the safest it's ever been!!" she wrote. "I wish our great military men and women could just stay here. I am so excited for the parade celebrating the 250th anniversary of our United States Army!!" Protests of the Trump administration's immigration crackdown are planned across the country to counterprogram the parade, with the flagship "No Kings" protest occurring in Philadelphia. Nine small protests are also expected in Washington, according to the Secret Service and local officials. Trump has warned protesters will be met with "heavy force." On Friday, he disputed the characterization of him as a king. "I don't feel like a king. I have to go through hell to get stuff approved," he said, adding, "No, no, we're not a king. We're not a king at all."

RFK Jr.'s New Vaccine Panel Includes Two Paid Witnesses Against Merck
RFK Jr.'s New Vaccine Panel Includes Two Paid Witnesses Against Merck

Bloomberg

time6 minutes ago

  • Bloomberg

RFK Jr.'s New Vaccine Panel Includes Two Paid Witnesses Against Merck

Two new vaccine advisers tapped by Health and Human Services Secretary Robert F. Kennedy Jr. have served as paid expert witnesses for plaintiffs suing Merck & Co. over some of the drug company's inoculations targeting measles, mumps and cancer. Robert Malone, a scientist who has espoused debunked theories about the safety of vaccines, along with Martin Kulldorff, a Harvard-trained epidemiologist who has studied their side effects, were added to the Centers for Disease Control and Prevention's committee on immunization policy. Both men have been hired by plaintiffs' attorneys in the past to opine about Merck's handling of its vaccines, court filings show.

Bernie Sanders Introduces Bill Backing RFK Jr., Elon Musk Priority
Bernie Sanders Introduces Bill Backing RFK Jr., Elon Musk Priority

Newsweek

time7 minutes ago

  • Newsweek

Bernie Sanders Introduces Bill Backing RFK Jr., Elon Musk Priority

Based on facts, either observed and verified firsthand by the reporter, or reported and verified from knowledgeable sources. Newsweek AI is in beta. Translations may contain inaccuracies—please refer to the original content. Senator Bernie Sanders is leading a new bill to address a key priority of Robert F. Kennedy Jr., who serves as President Donald Trump's Health and Human Services Secretary. Why It Matters Sanders, a Vermont independent, alongside Senator Angus King, a Maine independent, introduced the "End Prescription Drug Ads Now Act," which, if passed, would ban prescription drug advertising on TV, radio, print and digital platforms as well as social media. Critics say these ads contribute to the high price of healthcare while doing little to improve care in the United States, though proponents say the advertisements can improve patients' knowledge of healthcare. Most wealthy countries, with the U.S. and New Zealand being two notable exceptions, ban pharmaceutical drug advertisements. The bill also represents an issue where Sanders, viewed as perhaps the most progressive senator, has found common ground with Kennedy inside the Trump administration, though the secretary has not commented on this bill specifically. What to Know Sanders and King announced the legislation on Thursday, highlighting that the pharmaceutical industry spent more than $5 billion on TV ads in 2024 and that many of these drugs cost more in the U.S. than in other countries that do not allow drug companies to run ads on TV. "The American people are sick and tired of greedy pharmaceutical companies spending billions of dollars on absurd TV commercials pushing their outrageously expensive prescription drugs," Sanders said, describing the fact that the U.S. stands mostly alone in allowing pharmaceutical ads as an "international embarrassment." vSenator Bernie Sanders, a Vermont independent, questions U.S. Secretary of Health and Human Services Robert F. Kennedy Jr. during a committee hearing on May 14, 2025 in Washington, D.C. vSenator Bernie Sanders, a Vermont independent, questions U.S. Secretary of Health and Human Services Robert F. Kennedy Jr. during a committee hearing on May 14, 2025 in Washington, director of communications Anna Bahr confirmed to Newsweek his office has reached out to Republicans to join the bill. Bahr pointed to lobbying from the pharmaceutical and health insurance industries as to why the U.S. has not joined other countries in bannign the ads. "Over the past 25 years, the drug companies have spent $8.5 billion on lobbying. Today, they have some 1,800 well-paid lobbyists in Washington, D.C. – including former leaders of the Republican and Democratic parties," she said in a statement to Newsweek. "Unbelievably, that is more than three lobbyists for every member of Congress. During that same period, they have provided over $700 million in campaign contributions. And they are equal opportunity contributors. They contribute heavily to both Republican and Democratic candidates." Secretary Kennedy—as well as Elon Musk, who previously served in Trump's administration—have expressed support for ending pharmaceutical advertising. "Let's get President Trump back in the White House and me to DC so we can ban pharmaceutical advertising," Kennedy wrote in a post to X (formerly Twitter) on November 3, 2024. During his own presidential campaign, Kennedy said he would have issued an executive order ending the advertisements on his first day in office. Newsweek reached out to DHS for comment via the department's press contact form. Caleb Alexander, professor of epidemiology at the Johns Hopkins University Bloomberg School of Public Health, told Newsweek that while a potential ban's impact on drug prices remains uunclear, there would be benefits to ending these advertisements. Pharmaceutical advertisements can drive up "inappropriate demand" for prescription drugs in settings where they may not be needed, he said. "In terms of the potential benefits of banning [direct-to-consumer advertisements], the most immediate and likely is that it would temper demand for products in settings where they may not be needed," Alexander said. The U.S. has "evolved to believe" the benefits of the ads, such as empowering patients to identify health concerns, outweigh the risks, though much of the research on the topic indicates that the benefits may not be worth the drawbacks, he said. What People Are Saying Alexander told Newsweek: "Direct to consumer advertising has been a lightning rod for controversy, and it remains a curious and unique feature of the U.S. marketplace. While a ban on direct advertising may be welcomed by many, it's not going to fundamentally transform the marketplace for prescription drugs in the United States, simply because DTCA is highly concentrated among a small number of products. It may be a reasonable political and public health target, but I think that if you just look at the way the dollars flow, there's vastly more money spent on marketing drugs to prescribers." Senator Angus King wrote in a statement: "The widespread use of direct-to-consumer advertising by pharmaceutical companies drives up costs and doesn't necessarily make patients healthier. The End Prescription Drug Ads Now Act would prohibit direct-to-consumer advertising of pharmaceutical drugs to protect people. This bill is a great step to ensure that patients are getting the best information possible and from the right source: their providers and not biased advertisements." Elon Musk wrote to X in November 2024: "No advertising for pharma." What Happens Next It's unclear whether a majority of senators are also in support of the bill. So far, Democratic Senators Chris Murphy of Connecticut, Peter Welch of Vermont, Jeff Merkley of Oregon and Dick Durbin of Illinois have co-sponsored the bill, according to Sanders' office.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store